Skip to main content

Table 2 Baseline characteristics of CAD and NCAD groups before surgery

From: Association of chemerin mRNA expression in human epicardial adipose tissue with coronary atherosclerosis

  CAD (n = 37) NCAD (n = 16) P
Age (years) 59.1 ± 8.0 54.3 ± 9.4 NS
Male (%) 30 (81.1) 12 (75.0) NS
Hypertension (%) 27 (73.0) 3 (18.8) < 0.001
T2 DM (%) 11 (29.7) 1 (6.2) NS
BMI (kg/m2) 27.1 ± 3.4 24.3 ± 2.6 0.004
Waist circumference (cm) 94.7 ± 9.2 85.5 ± 9.8 0.002
LVEF (%) 56.2 ± 10.1 60.1 ± 8.1 NS
Systolic blood pressure (mmHg) 129.3 ± 20.7 127.1 ± 19.5 NS
Diastolic blood pressure (mmHg) 78.1 ± 12.4 79 ± 14.0 NS
Aspirin (%) 16 (43.2) 0 (0) 0.005
Nitrates (%) 37 (100) 0 (0) < 0.001
ACEIs/ARBs (%) 22 (59.5) 9 (56.2) NS
Statins (%) 25 (67.6) 0 (0) < 0.001
β-blockers (%) 35 (94.6) 3 (18.8) < 0.001
Calcium channel blockers (%) 13 (35.1) 0 (0) 0.017
Insulin (%) 5 (13.5) 1 (6.2) NS
Oral hypoglyceimic agents (%) 9 (24.3) 1 (6.2) NS
Diuretics (%) 2 (5.4) 16 (100) < 0.001
Antibiotics (%) 6 (16.2) 4 (25.0) NS
Fasting glucose (mmol/L) 6.08 (5.25, 7.45) 5.19 (4.86, 5.51) 0.002
HbA1C (%) 6.3 ± 0.8 6.0 ± 0.6 NS
Fasting insulin (μU/mL) 4.67 (2.43, 45.75) 2.27 (1.77, 3.06) 0.031
HOMA-IR 1.43 (0.69, 1.32) 0.53 (0.44, 0.68) 0.013
Total cholesterol (mmol/L) 4.44 ± 1.00 4.83 ± 0.73 NS
HDL-C (mmol/L) 1.07 ± 0.24 1.25 ± 0.22 0.014
LDL-C (mmol/L) 2.68 ± 0.81 2.89 ± 0.53 NS
Triglycerides (mmol/L) 1.88 ± 1.09 1.77 ± 1.49 NS
Urea nitrogen (mmol/L) 6.82 ± 2.58 7.67 ± 2.46 NS
Serum creatinine (μmol/L) 89.9 ± 21.3 83.5 ± 20.1 NS
Uric acid (μmol/L) 380.2 ± 111.1 393.3 ± 96.8 NS
hsCRP (mg/L) 1.95 (0.98, 6.75) 1.07 (0.51, 1.66) 0.003
  1. Data are presented as mean ± SD, median (lower quartile, upper quartile), or number (%), P value represents CAD group vs. NCAD group. Abbreviations: CAD, coronary artery disease; T2DM, type 2 diabetes; BMI: body mass index; LVEF, left ventricular ejection fraction; ACEIs: angiotensin converting enzyme inhibitors; ARBs: angiotensin II type 1 receptor blockers; HbA1C, hemoglobin A1C; HOMA-IR: homeostasis model assessment of insulin resistance; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; hsCRP, high sensitivity C-reactive protein; NS, non-significance.